Predictive value of lipoprotein (a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis

F Vazirian, M Sadeghi, T Kelesidis, MJ Budoff… - Nutrition, Metabolism …, 2023 - Elsevier
Aims Studies have indicated inconsistent results regarding the association between plasma
levels of Lipoprotein (a)[Lp (a)] and coronary artery calcification (CAC). We performed a …

Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein (a) and Low-Density Lipoprotein Cholesterol

N Marrero, K Jha, AC Razavi, E Boakye… - Circulation …, 2024 - Am Heart Assoc
BACKGROUND: Aortic valve calcification (AVC), Lp (a)[lipoprotein (a)], and low-density
lipoprotein cholesterol (LDL-C) are associated with severe aortic stenosis (AS). We aimed to …

Evaluation of lipoprotein (a) in the prevention and management of atherosclerotic cardiovascular disease: a survey among the Lipid Clinics Network

AL Catapano, L Tokgözoğlu, M Banach, M Gazzotti… - Atherosclerosis, 2023 - Elsevier
Abstract Background and aims The European Atherosclerosis Society (EAS) Lipid Clinics
Network promoted a survey in order to identify and understand how and when lipoprotein …

Triglyceride metabolism modifies lipoprotein (a) plasma concentration

M Ramos-Cáceres, I Lamiquiz-Moneo… - The Journal of …, 2022 - academic.oup.com
Abstract Background Lipoprotein (a)(Lp (a)) is a significant cardiovascular risk factor.
Knowing the mechanisms that regulate its concentration can facilitate the development of Lp …

Effects of nut consumption on blood lipids and lipoproteins: A comprehensive literature update

M Guasch-Ferré, AJ Tessier, KS Petersen, PA Sapp… - Nutrients, 2023 - mdpi.com
In the present review, we provide a comprehensive narrative overview of the current
knowledge on the effects of total and specific types of nut consumption (excluding nut oil) on …

[HTML][HTML] Bayesian estimation of gene constraint from an evolutionary model with gene features

T Zeng, JP Spence, H Mostafavi, JK Pritchard - bioRxiv, 2023 - ncbi.nlm.nih.gov
Measures of selective constraint on genes have been used for many applications including
clinical interpretation of rare coding variants, disease gene discovery, and studies of …

[HTML][HTML] Trends in testing and prevalence of elevated Lp (a) among patients with aortic valve stenosis

HS Bhatia, GS Ma, A Taleb, M Wilkinson, AM Kahn… - Atherosclerosis, 2022 - Elsevier
Background and aims Lipoprotein (a)[Lp (a)] is causally associated with aortic valve stenosis
(AS) but Lp (a) testing among AS patients is not broadly incorporated into clinical practice …

Elevated lipoprotein (a) levels and risk of peripheral artery disease outcomes: A systematic review

W Masson, M Lobo, L Barbagelata… - Vascular …, 2022 - journals.sagepub.com
Background: Despite strong association of elevated lipoprotein (a)(Lp (a)) levels with
incident coronary and cerebrovascular disease, data for incident peripheral artery disease …

Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles¿ Qué parámetros debe incluir un perfil lipídico básico?

T Arrobas-Velilla, C Guijarro… - Revista Clínica de …, 2023 - SciELO Espana
Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en
nuestro país. El control adecuado de las alteraciones del metabolismo lipídico es un reto …

New horizons: revival of lipoprotein (a) as a risk factor for cardiovascular disease

P Nestel, WJ Loh, NC Ward… - The Journal of Clinical …, 2022 - academic.oup.com
The status of lipoprotein (a)[Lp (a)] as a cardiovascular risk factor has been resurrected by
advances in genetics. Mendelian randomization studies show a causal link of Lp (a) with …